{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:29:05Z","timestamp":1648967345662},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00467-017-3825-y","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T15:22:20Z","timestamp":1509636140000},"page":"1161-1163","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteinuria in a male adolescent with hearing loss: Answers"],"prefix":"10.1007","volume":"33","author":[{"given":"G\u00fcl\u015fah","family":"Kaya Aksoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"\u00c7omak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Koyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Akman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"key":"3825_CR1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1186\/1471-2369-15-72","volume":"15","author":"S Waldek","year":"2014","unstructured":"Waldek S, Feriozzi S (2014) Fabry nephropathy: a review\u2014how can we optimize the management of nephropathy? BMC Nephrol 15:1471\u20132369","journal-title":"BMC Nephrol"},{"key":"3825_CR2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0272-6386(12)80518-X","volume":"15","author":"HC Chen","year":"1990","unstructured":"Chen HC, Tsai JH, Lai YH, Guh JY (1990) Renal changes in heterozygous Fabry\u2019s disease\u2014a family study. Am J Kidney Dis 15:180\u2013183","journal-title":"Am J Kidney Dis"},{"key":"3825_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfs526","volume":"28","author":"W Terryn","year":"2013","unstructured":"Terryn W, Cochat P, Froissart R, Ortiz A, Pirson Y, Poppe B, Serra A, Van Biesen W, Vanholder R, Wanner C (2013) Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European renal best practice. Nephrol Dial Transplant 28:505\u2013517","journal-title":"Nephrol Dial Transplant"},{"key":"3825_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.10.019","volume":"353","author":"GE Linthorst","year":"2005","unstructured":"Linthorst GE, Vedder AC, Aerts JM, Hollak CE (2005) Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta 353:201\u2013203","journal-title":"Clin Chim Acta"},{"key":"3825_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10545-010-9261-9","volume":"34","author":"A Gal","year":"2011","unstructured":"Gal A, Hughes DA, Winchester B (2011) Toward a consensus in the laboratory diagnostics of Fabry disease\u2014recommendations of a European expert group. J Inherit Metab Dis 34:509\u2013514","journal-title":"J Inherit Metab Dis"},{"key":"3825_CR6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.ajkd.2010.10.046","volume":"57","author":"E Paschke","year":"2011","unstructured":"Paschke E, Fauler G, Winkler H, Schlagenhauf A, Plecko B, Erwa W, Breunig F, Urban W, Vujkovac B, Sunder-Plassmann G, Kotanko P (2011) Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study. Am J Kidney Dis 57:673\u2013681","journal-title":"Am J Kidney Dis"},{"key":"3825_CR7","doi-asserted-by":"crossref","unstructured":"Selvarajah M, Nicholls K, Hewitson TD, Becker GJ (2011) Targeted urine microscopy in Anderson\u2013Fabry disease: a cheap, sensitive and specific diagnostic technique. Nephrol Dial Transplant 26:3195\u20133202","DOI":"10.1093\/ndt\/gfr084"},{"key":"3825_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30","journal-title":"Orphanet J Rare Dis"},{"key":"3825_CR9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Investig 34:236\u2013242","journal-title":"Eur J Clin Investig"},{"key":"3825_CR10","first-page":"37","volume":"5","author":"C Ellaway","year":"2016","unstructured":"Ellaway C (2016) Paediatric Fabry disease. Transl Pediatr 5:37\u201342","journal-title":"Transl Pediatr"},{"key":"3825_CR11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/gim.2016.55","volume":"18","author":"R Schiffmann","year":"2016","unstructured":"Schiffmann R, Fuller M, Clarke LA, Aerts JM (2016) Is it Fabry disease? Genet Med 18:1181\u20131185","journal-title":"Genet Med"},{"key":"3825_CR12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2015.10.007","volume":"117","author":"RJ Hopkin","year":"2016","unstructured":"Hopkin RJ, Jefferies JL, Laney DA, Lawson VH, Mauer M, Taylor MR, Wilcox WR, Fabry Pediatric Expert Panel (2016) The management and treatment of children with Fabry disease: a United States-based perspective. Mol Genet Metab 117:104\u2013113","journal-title":"Mol Genet Metab"},{"key":"3825_CR13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000448968","volume":"134","author":"D Oder","year":"2016","unstructured":"Oder D, Nordbeck P, Wanner C (2016) Long term treatment with enzyme replacement therapy in patients with Fabry disease. Nephron 134:30\u201336","journal-title":"Nephron"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3825-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3825-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3825-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T12:57:18Z","timestamp":1528203438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3825-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3825"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3825-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]}}}